Quarterly report pursuant to Section 13 or 15(d)

Basis of Presentation and Summary of Significant Accounting Policies (Details)

v3.20.2
Basis of Presentation and Summary of Significant Accounting Policies (Details)
$ in Thousands
9 Months Ended
Jan. 01, 2018
USD ($)
reportingUnit
Sep. 30, 2020
USD ($)
reportingUnit
Sep. 30, 2020
USD ($)
segment
Dec. 31, 2019
USD ($)
New Accounting Pronouncements or Change in Accounting Principle [Line Items]        
Number of reporting units | reportingUnit 2 2    
Goodwill   $ 3,241 $ 3,241 $ 3,241
Number of reportable segments   2 2  
Performance Enzymes [Member]        
New Accounting Pronouncements or Change in Accounting Principle [Line Items]        
Goodwill, allocated percent 76.00%      
Goodwill $ 2,400      
Novel Biotherapeutics [Member]        
New Accounting Pronouncements or Change in Accounting Principle [Line Items]        
Goodwill, allocated percent 24.00%      
Goodwill $ 800